https://doi.org/10.4081/itjm.2023.1652

Prevalence and determinants of permanent atrial fibrillation in post-menopausal hypertensive women

Vol. 17 No. 2 (2023)
Published: 2 October 2023
Atrial fibrillation, postmenopausal women, hypertension, obesity, left atrial
Abstract Views: 382
PDF: 167
HTML: 1
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Maria Maiello
Department of Cardiology Equipe, ASL Brindisi, Italy.
Annagrazia Cecere
Department of Cardiac-Thoracic-Vascular Science and Public Health, University of Padua, Italy.
Marco Matteo Ciccone
Cardiovascular Diseases Section, Department of Emergency and Organ Transplantation (DETO), University of Bari, Italy.
Pasquale Palmiero
pasquale.palmiero@uniba.it
Medical School, University of Bari; Cardiology Equipe, Brindisi site, Italy.

Objective. We studied the prevalence and major predisposing factors of permanent atrial fibrillation (PAF) in a population of hypertensive post-menopausal (HPMW) women. Materials and Methods. We enrolled 125 consecutive HPMW with PAF, 125 HPMW in sinus rhythm were the control group (CG). Women with valvular heart disease, coronary artery disease, WPW syndrome, left ventricular (LV) ejection fraction <45% and thyroid disorders were excluded. The mean age was similar: 53±3 years for women on PAF and 51±6 for women with sinus rhythm (P<0.45). All women who underwent M-B mode echocardiography, LV mass, function, and left atrial (LA) volume were assessed according to American Society of Echocardiography guidelines. Diabetes was assessed according to American Diabetes Association guidelines. Results. In a population of 8945 consecutive women, 4497 were hypertensive (50.2%) and 125 were on PAF (0.3%). We observed a highly significant difference between the two groups in relation to obesity: 31 (24.8%) in the AF-group and 15 (12%) in CG, Chi-squared 10, P<0.0016, OR 2.8, 95%; to increased LA volume: 37 (29.6%) in AF-group and 13 (10.4%) in CG, Chi-squared 14.4, P<0.0001, OR 3.62, 95%. No difference in diabetes: 30 (24%) in AFgroup and 28 (22.4%) in CG, Chi-squared 0.09, P<0.76, OR 1.09, 95%, and LV diastolic dysfunction (LVDD): 24 (19.2%) in AF-group and 20 (16%) in CG, Chi-squared 0.44, P<0.5, OR 1.25, 95%. In contrast to what was expected LV hypertrophy had a lower incidence of 59 (47.2%) in AF-group than in CG 84 (67.2%), Chi-squared 10.21, P<0.0014, OR 0.44, 95%. Conclusions. The prevalence of PAF in HPMW is not elevated, obesity and increased LA volume are strong determinants of PAF, not depending on age. LVDD, LV hypertrophy, and diabetes status seem not to play a relevant role as PAF determinants.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

PlumX Metrics

PlumX Metrics  provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, Age Distribution, and Gender of Patients With Atrial Fibrillation: Analysis and Implications. Arch Intern Med 1995;155:469-73. DOI: https://doi.org/10.1001/archinte.155.5.469
Emdin CA, Wong CX, Hsiao AJ, et al. Atrial fibrillation as a risk factor for cardiovascular disease and death in women compared with men: Systematic review and meta-analysis of cohort studies. BMJ 2016;352. DOI: https://doi.org/10.1136/bmj.h7013
Kavousi M. Differences in Epidemiology and Risk Factors for Atrial Fibrillation Between Women and Men. Front Cardiovasc Med 2020;7. DOI: https://doi.org/10.3389/fcvm.2020.00003
Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics - 2018 update: A report from the American Heart Association. Circulation 2018;137:E67-492. DOI: https://doi.org/10.1161/CIR.0000000000000573
Wachtell K, Devereux RB, Okin PM, et al. The left atrium, atrial fibrillation, and the risk of stroke in hypertensive patients with left ventricular hypertrophy. Ther Adv Cardiovasc Dis 2008;2:507-13. DOI: https://doi.org/10.1177/1753944708093846
Sanchez JM, Jolly SE, Dewland TA, et al. Incident Atrial Fibrillation among American Indians in California. Circulation 2019;140:1605-6. DOI: https://doi.org/10.1161/CIRCULATIONAHA.119.042882
Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022;145:e895-e1032. DOI: https://doi.org/10.1161/CIR.0000000000001073
Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977;55:613-8. DOI: https://doi.org/10.1161/01.CIR.55.4.613
Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2016;29:277-314. DOI: https://doi.org/10.1016/j.echo.2016.01.011
Palmiero P, Maiello M, Zito A, Ciccone M. Hypertensive Cardiomyopathy in asymptomatic patients: a neglected diagnosis. Curr Hypertens Rev 2014;10:239-45. DOI: https://doi.org/10.2174/157340211004150319123635
Vitale C, Miceli M, Rosano GMC. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention. Climacteric 2007;10 Suppl 2:16-20. DOI: https://doi.org/10.1080/13697130701602712
Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997;96:2455-61. DOI: https://doi.org/10.1161/01.CIR.96.7.2455
Bateman RM, Sharpe MD, Jagger JE, et al. 36th International Symposium on Intensive Care and Emergency Medicine. Crit Care 2016;20.
Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104:2886-91. DOI: https://doi.org/10.1161/hc4901.101760
Pelat M, Verwaerde P, Merial C, et al. Impaired atrial M(2)-cholinoceptor function in obesity-related hypertension. Hypertens (Dallas, Tex 1979) 1999;34:1066-72. DOI: https://doi.org/10.1161/01.HYP.34.5.1066
Stritzke J, Markus MRP, Duderstadt S, et al. The aging process of the heart: obesity is the main risk factor for left atrial enlargement during aging the MONICA/KORA (monitoring of trends and determinations in cardiovascular disease/cooperative research in the region of Augsburg) study. J Am Coll Cardiol 2009;54:1982-9. DOI: https://doi.org/10.1016/j.jacc.2009.07.034
Reddigan JI, Ardern CI, Riddell MC, Kuk JL. Relation of physical activity to cardiovascular disease mortality and the influence of cardiometabolic risk factors. Am J Cardiol 2011;108:1426-31. DOI: https://doi.org/10.1016/j.amjcard.2011.07.005
Azarbal F, Stefanick ML, Salmoirago-Blotcher E, et al. Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal women. J Am Heart Assoc 2014;3. DOI: https://doi.org/10.1161/JAHA.114.001127
Aizer A, Gaziano JM, Cook NR, et al. Relation of vigorous exercise to risk of atrial fibrillation. Am J Cardiol 2009;103:1572-7. DOI: https://doi.org/10.1016/j.amjcard.2009.01.374
Maiello M, Cecere A, Ciccone MM, Palmiero P. Left atrial enlargement prevalence in normotensive, normoglycemic, obese, postmenopausal women and its correlation with left ventricular hypertrophy and diastolic function. An echocardiographic real world observational study. World Heart J 2019;11.
Wang TJ, Parise H, Levy D, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004;292:2471-7. DOI: https://doi.org/10.1001/jama.292.20.2471
Messerli FH, Ventura HO, Reisin E, et al. Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation 1982;66:55-60. DOI: https://doi.org/10.1161/01.CIR.66.1.55
Maiello M, Zito A, Cecere A, et al. Left ventricular diastolic dysfunction in normotensive postmenopausal women with type 2 diabetes mellitus. Cardiol J 2017;24:51-6. DOI: https://doi.org/10.5603/CJ.a2016.0064
Asferg CL, Nielsen SJ, Andersen UB, et al. Relative atrial natriuretic peptide deficiency and inadequate renin and angiotensin II suppression in obese hypertensive men. Hypertension 2013;62:147-53. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.111.00791
Parkash R, Green MS, Kerr CR, et al. The association of left atrial size and occurrence of atrial fibrillation: a prospective cohort study from the Canadian Registry of Atrial Fibrillation. Am Heart J 2004;148:649-54. DOI: https://doi.org/10.1016/j.ahj.2004.04.029
Huxley RR, Filion KB, Konety S, Alonso A. Metaanalysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol 2011;108:56-62. DOI: https://doi.org/10.1016/j.amjcard.2011.03.004
Alves-Cabratosa L, García-Gil M, Comas-Cufí M, et al. Diabetes and new-onset atrial fibrillation in a hypertensive population. Ann Med 2016;48:119-27. DOI: https://doi.org/10.3109/07853890.2016.1144930
Bonapace S, Rossi A, Cicoira M, et al. Echocardiographically Derived Pulse Wave Velocity and Diastolic Dysfunction Are Associated with an Increased Incidence of Atrial Fibrillation in Patients with Systolic Heart Failure. Echocardiography 2016;33:1024-31. DOI: https://doi.org/10.1111/echo.13230
Tsang TSM, Barnes ME, Gersh BJ, et al. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002;90:1284-9. DOI: https://doi.org/10.1016/S0002-9149(02)02864-3
Okin PM, Wachtell K, Devereux RB, et al. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. JAMA 2006;296:1242-8. DOI: https://doi.org/10.1001/jama.296.10.1242

How to Cite

Maiello, M., Cecere, A., Ciccone, M. M., & Palmiero, P. (2023). Prevalence and determinants of permanent atrial fibrillation in post-menopausal hypertensive women. Italian Journal of Medicine, 17(2). https://doi.org/10.4081/itjm.2023.1652
Copyright (c) 2023 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.


Similar Articles

You may also start an advanced similarity search for this article.